Stephanie Grim
Pediatrics · Oklahoma City, OKNPI 1124066980
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $568 and has fallen 53.9% since, to $262 in 2025. Among pediatrics clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$407
- Supernus Pharmaceuticals, Inc.$324
- Merck$179
- Kaleo, Inc.$170
- Sanofi Pasteur Inc.$138
- Corium, LLC$138
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,435100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $407 |
| Supernus Pharmaceuticals, Inc. | 15 | $324 |
| Merck | 12 | $179 |
| Kaleo, Inc. | 10 | $170 |
| Sanofi Pasteur Inc. | 9 | $138 |
| Corium, LLC | 7 | $138 |
| Ultragenyx Pharmaceutical Inc. | 5 | $112 |
| Seqirus USA Inc | 6 | $106 |
| Tris Pharma Inc | 7 | $100 |
| Sobi, Inc | 7 | $96 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| AstraZeneca(2 entities) | 3 | $70 |
| Verrica Pharmaceuticals Inc. | 3 | $61 |
| Nestle Healthcare Nutrition Inc. | 3 | $55 |
| Alk-abello, Inc | 3 | $51 |
| Biomarin Pharmaceutical Inc. | 2 | $38 |
| Cranial Technologies, Inc | 2 | $36 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| AbbVie | 1 | $25 |
| Novartis | 1 | $24 |
| Mylan Pharmaceuticals Inc. | 1 | $23 |
| Biomerieux Inc | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| Shire North American Group Inc | 1 | $20 |
| Sarepta Therapeutics, Inc. | 1 | $19 |
| Mission Pharmacal Company | 1 | $18 |
| Rhodes Pharmaceuticals L.p. | 1 | $15 |
| GSK | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $11 |
How this compares
$2,435 in reported general payments places this provider in the 90th percentile of 568 pediatrics providers in Oklahoma.
Other pediatrics in Oklahoma City
- Scott MelsonOklahoma City$11K
- Julie MayOklahoma City$5K
- Rachel SpragueOklahoma City$4K
- Brittany FarquharOklahoma City$3K
- Hamed AlbiekOklahoma City$3K
- Branson KesterOklahoma City$3K
- Diana FarrowOklahoma City$2K
- Robert MooreOklahoma City$2K
- Jordan PopeOklahoma City$2K
- Jennifer CooperOklahoma City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.